Intravascular Access of COVID-19 Patient Under Personal Protective Equipment

Lazarski University

Status: Completed

Conditions: Emergencies; Cardiac Arrest

Treatments: Device: Intravenous access; Device: Intraosseous access

Study type: Interventional

Funder types: Other

Identifiers

NCT04366297

IO_PPE_MS_1

Details and patient eligibility

About

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

Enrollment: 41 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• paramedic
• consent voluntary participation in the study
• none experience in resuscitation with personal protective equipment

Exclusion criteria

• refusal to participate in the study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Single Blind

---

41 participants in 2 patient groups

Standard of Care (Intravenous Cannula)

Experimental group

Description:

obtaining intravascular access using a ready standard intravenous cannula

Treatment:

Device: Intravenous access

IO access using NIO® set

Experimental group

Description:

receive an IO line in the proximal tibia localization. IO lines are placed using an FDA-approved device called an NIO®.

Treatment:

Device: Intraosseous access